,61 Upregulation of the YAP/TAZ pathway was found in cutaneous melanoma tissue of patients who developed resistance to BRAF-inhibitor or RAF + MEK-inhibitor therapy.62 This evidence concerns the gene TAFAZZIN and cutaneous melanoma.